Related Experiment Video
Updated: Jun 6, 2025
08:47
Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
9.6K
Incretin hormones and obesity.
Constanza Alcaino1, Frank Reimann1, Fiona M Gribble1
1Institute of Metabolic Science Metabolic Research Laboratories, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
The Journal of Physiology
|November 22, 2024
Summary
Incretin hormones like glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are key to regulating metabolism after meals. Understanding their roles is vital for developing new diabetes and obesity treatments.
Area of Science:
- Endocrinology
- Metabolism
- Pharmacology
Background:
- Incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), regulate postprandial metabolism.
- These hormones are secreted by intestinal enteroendocrine cells and act on pancreatic islets and the brain.
- Their roles in insulin secretion and food intake modulation are critical.
Purpose of the Study:
- To highlight the physiological and pharmacological importance of incretin hormones.
- To underscore the significance of GLP-1 and GIP in metabolic regulation.
- To provide context for the development of incretin-based therapeutics.
Main Methods:
- Review of physiological roles of GLP-1 and GIP.
- Analysis of incretin hormone secretion and action mechanisms.
- Examination of therapeutic applications of incretin receptor agonists.
Main Results:
- GLP-1 and GIP are crucial for coordinating postprandial metabolism.
- These hormones influence insulin secretion and control food intake.
- Agonists targeting GLP-1 and GIP receptors are effective in treating type 2 diabetes and obesity.
Conclusions:
- Incretin hormones are central to metabolic homeostasis.
- Understanding incretin physiology and pharmacology is essential for advancing treatments for metabolic diseases.
- Ongoing research into incretin-based drugs promises improved therapeutic efficacy.
More Related Videos
Related Concept Videos
01:24Glucagon-like Receptor Agonists
298
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
298
01:30Regulation of Food Intake
193
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
193
01:24Obesity
379
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
379
01:16Hormones Regulating Blood Glucose
3.1K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.1K
01:40Hormonal Regulation
43.2K
Hormones regulate a significant portion of digestion through activation of the neuroendocrine system. The neuroendocrine system of digestion contains many different hormones all with multiple functions that are both, directly and indirectly, involved in digestion.
43.2K
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.1K